Get the latest Science News and Discoveries

FDA Approves Journavx Drug to Treat Pain Without Addiction Risk


None

Get the Android app

Or read this on New York Times

Read more on:

Photo of Pain

Pain

Photo of journavx drug

journavx drug

Photo of addiction risk

addiction risk

Related news:

News photo

Study: Orally Administered CBD Significantly Reduces Pain, Other Symptoms in Patients with Nail-Patella Syndrome

News photo

Expert Reveals Why The FDA Finally Banned 'Red 3' Dye

News photo

University Hospitals now offering ultra-minimally invasive endoscopic spine surgery for patients experiencing back pain - EurekAlert